Innoviva (INVA) Dividends Paid - Common (2014 - 2022)
Innoviva's (INVA) quarterly Dividends Paid - Common came in at $69.8 million in Q3 2022, up 50.59% YoY from $46.4 million in Q3 2021, and up 631.23% on a QoQ basis from $9.5 million in Q2 2022.
Innoviva (INVA) Dividends Paid - Common (2014 - 2022) Analysis & Trends
Innoviva (INVA) has 9 years of Dividends Paid - Common data on file, last reported at $69.8 million in Q3 2022.
- Quarterly Dividends Paid - Common rose 50.59% year-over-year to $69.8 million in Q3 2022, while the trailing twelve-month figure through Sep 2023 was $69.8 million (down 47.2% YoY) and the FY2022 annual result came in at $69.8 million, up 17.41% from the prior year.
- Dividends Paid - Common grew to $69.8 million in Q3 2022, from $9.5 million in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $69.8 million in Q3 2022 to a low of -$10.5 million in Q4 2019.
- A 5-year average of $13.1 million and a median of $8.0 million in 2022 frame the typical range for Dividends Paid - Common.
- Annual changes were most pronounced in 2019 — Dividends Paid - Common sank 443.72% — and 2020, when it jumped 110372.73%.
- Tracing INVA's Dividends Paid - Common over 5 years: stood at $3.1 million in 2018, then slumped by 443.72% to -$10.5 million in 2019, then surged by 123.83% to $2.5 million in 2020, then jumped by 1745.46% to $46.4 million in 2021, then soared by 50.59% to $69.8 million in 2022.
- The last three Dividends Paid - Common figures came in at $69.8 million (Q3 2022), $9.5 million (Q2 2022), and $6.5 million (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 34.60 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 69.81 Mn |
| Sep 30, 2022 | 69.81 Mn |
| Jun 30, 2022 | 9.55 Mn |
| Jun 30, 2022 | 9.55 Mn |
| Mar 31, 2022 | 6.51 Mn |
| Mar 31, 2022 | 6.51 Mn |
| Sep 30, 2021 | 46.36 Mn |
| Sep 30, 2021 | 46.36 Mn |
| Jun 30, 2021 | 20.16 Mn |
| Jun 30, 2021 | 20.16 Mn |
| Mar 31, 2021 | 21.29 Mn |
| Mar 31, 2021 | 21.29 Mn |
| Dec 31, 2020 | 2.51 Mn |
| Dec 31, 2020 | 2.51 Mn |
| Jun 30, 2020 | 12.15 Mn |
| Jun 30, 2020 | 12.15 Mn |
| Mar 31, 2020 | 15.81 Mn |
| Mar 31, 2020 | 15.81 Mn |
| Dec 31, 2019 | -10.54 Mn |
| Dec 31, 2019 | -10.54 Mn |